Researchers now use generative AI to design novel viruses for medical and biological study. Current governance fails to keep pace with these capabilities, creating significant biosafety risks. Scientific American warns that this gap leaves the door open for accidental or intentional misuse. Practitioners must prioritize strict alignment and oversight protocols.